En

January 21, 2021
Online Event

The MedChem Division of the German Chemical Society (GDCh) would like to invite you to the next #MedChemCASES online seminar which will be given by Michiel Van Gool, Principal Scientist at Janssen R&D, Spain.

The online seminar is free of charge, but prior registration is needed. Please sign up here:
https://zoom.us/webinar/register/WN_MPG6HfMZSOeRrFbh_vC6gw

For more information on #MedChemCASES:
https://www.gdch.de/netzwerk-strukturen/fachstrukturen/medizinische-chemie/veranstaltungen/medchemcases.html

Organised by:
  • Division of Medicinal Chemistry of the German Chemical Society (GDCh) (Germany)

January 26-28, 2021
Online Event

For more information please contact: matthias.neumann@dechema.de

Organised by:
  • Division of Medicinal Chemistry of the German Chemical Society (GDCh) (Germany)

February 4, 2021
Online Event

This event organized by the DMCCB, will feature six national and international speakers talking about «Targeting RNA by Small Molecules», a topic selected by the DMCCB members.

The programme includes talks from:

  • Kamal Azzaoui, Saverna Therapeutics, Basel, Switzerland
  • Michaela Frye, Deutsches Krebsforschungszentrum, Heidelberg, Germany
  • Amanda E. Hargrove, Duke University, Durham, United States
  • Iris Alroy, Anima Biotech, Bernardsville, United States
  • Matthew Disney, Scripps Research Institute, United States
  • tbd, Storm Therapeutics, Cambridge, United Kingdom

Attendees will have the possibility to present their work during the poster session in the form of short video presentations.

The goal of the symposium is to share cutting-edge scientific results and stimulate a stronger cooperation among persons working in different areas of medicinal chemistry and chemical biology. This event is directed towards scientists from industry and academia, as well as students interested in medicinal chemistry and chemical biology.

Deadline for poster submission is January 13, 2021.

For more information please contact: info@scg.ch

February 11-12, 2021
Online

This meeting brings together about 250 young European scientists and gives them the opportunity to present their most recent results. The topics presented cover all aspects of medicinal chemistry: chemical biology, chemoinformatics, SAR studies, ADMET, imaging, physical chemistry, biolabeling and diagnostic tools, drug vectorization, nanotechnologies, natural products, synthetic methodology, etc…

Deadline for registration: December 20, 2020

For more information please contact: young.medchem@sct-asso.fr

Organised by:
  • Société de Chimie Thérapeutique (SCT) (France)

February 24-25, 2021
Online Event

The key role of G protein-coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to be holding this 7½th interim meeting in the series on GPCR drug discovery, which will combine cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches.

For more information please contact: maggi@maggichurchouseevents.co.uk


Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)


EFMC Sponsored Event

February 25-27, 2021
Online

18th Hellenic Symposium on Medicinal Chemistry (HSMC-18) is organized by the Hellenic Society of Medicinal Chemistry (HSMC).

It continues the tradition of biannual meetings established since 35 years in Greece as a forum for the discussion of recent advances in medicinal chemistry. The topics include drug design and lead identification and optimization, protein-protein interactions and protein degradation, ADME/Tox properties, advances in Synthetic Medicinal Chemistry, Natural Products, Pharmacology as well as the impact of artificial intelligence in the integration of data- intensive practices to Drug Discovery.

Under this multidisciplinary research umbrella the  major therapeutic areas, such as treatment of inflammatory diseases, infectious diseases, metabolic disorders, cardiovascular diseases, neurodegenerative diseases and oncology will be discussed. Sections on Pharmaceutical Analysis will be integrated in the symposium program.

Deadline for Oral Communication submission: January 29, 2021

Deadline for Poster Presentation submission: February 5, 2021

For more information please contact: s.si@zita-congress.gr

Organised by:
  • Hellenic Society of Medicinal Chemistry (Greece)

March 8-10, 2021
Online Event

The online-event will focus on current developments, novel approaches and cutting-edge technologies in the field of medicinal chemistry and drug research with the following sessions: Degraders and Molecular Glues, Antiviral Agents, Young Investigators, Highlights in Medicinal Chemistry, First Disclosures & Case Studies, Covalent Binders and Fragments, Cryptic Binding Pockets and Novel Methods in Medicinal Chemistry and Case Studies. The scientific program will include lectures and poster presentations. It is the goal of the organizers to make FIMC 2021 an event of scientific excellence, attractive to both industrial and academic scientists in Medicinal Chemistry, Chemical Biology, and related fields of research.

Deadline for Oral Communication submission: January 15, 2021

Deadline for Poster submission: February 15, 2021

For more information please contact: felix.hausch@tu-darmstadt.de

 

Organised by:
  • Division of Medicinal Chemistry of the German Chemical Society (GDCh) (Germany)
  • German Pharmaceutical Society, Section of Pharmaceutical/Medicinal Chemistry (Germany)


EFMC Sponsored Event

Spring 2021
Eindhoven, The Netherlands

The Conference topics will include:

  • G-protein coupled receptors
  • Protein-protein interactions
  • Activity-based protein profiling
  • Carbohydrates/glycans
  • Cellular chemistry
  • Bioorthogonal and bioconjugation chemistry
  • Fragment-based drug design
  • Photopharmacology
Organised by:
  • Division Medicinal Chemistry & Chemical Biology, Royal Netherlands Chemical Society (KNCV-MCCB) (The Netherlands)

March 21-25, 2021
San Antonio, Texas

March 22-23, 2021
Online Event

Synthesis is at the heart of drug discovery and development. The industry has increasingly demanded higher quality clinical candidates and has sought to exploit less druggable biological targets. Densely functionalised small molecules with a high degree of synthetic complexity are often the result of these demands. Successful programmes therefore require the application of innovative synthesis in all stages of discovery and development. The medicinal chemist’s toolbox is also enhanced by the introduction of novel biosostrere, often made available only through the application of new synthetic methods. This symposium aims to celebrate the crucial role of synthesis in the success of drug discovery and development.

The three main themes of the symposium will be:

  • Innovative synthesis facilitating candidate discovery
  • Novel bioisosteres and methodology applicable to drug discovery
  • Overcoming challenges of scale-up and process scale chemistry
Deadline for abstract submission is January 29, 2021

For more information please contact: maggi@maggichurchouseevents.co.uk

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)

April 14-15, 2021
Online Event

With more than 49 FDA-approved small molecules, the field of kinase inhibition continues to attract significant investment from the drug discovery and development community. The 9th RSC/SCI symposium on kinases will encompass plenary lectures on emergent topics and case studies of ongoing programmes as well as successful past programmes. A range of topics including new screening approaches, brain penetrant kinase inhibitors, induced protein degradation, allosteric inhibitors and kinase inhibition for immuno-oncology will be covered, along with views and perspectives on the future of kinase inhibitor research.

For more information please contact: maggi@maggichurchouseevents.co.uk

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)

April 20, 2021
Online Event

This meeting seeks to explore and celebrate the chemistry that drives the development of modern nucleoside and nucleotide chemistry. It will bring together scientists who work at the interfaces of synthetic and biological chemistry to deliver new tools and insights for biology, and new leads for drug development.

Deadline for abstract submission is March 10, 2021

For more information please contact: maggi@maggichurchouseevents.co.uk

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)


EFMC Sponsored Event

April 29, 2021
Online

Cell surface transporters play a key role in human health and disease, both through their impact on drug disposition and as therapeutic targets in their own right. This third meeting in the series will feature talks on transporter structural biology, the impact of transporters on ADME and biodistribution, transporters as therapeutic targets and other aspects of transporters relevant to drug discovery and development. 

Bringing together leading exponents in the field from industry and academia, the meeting will appeal to medicinal chemists, DMPK scientists and other workers interested in the impact of transporters on human health.
 
For more information please contact: 

Organised by:

SCI's Fine Chemicals Group, RSC’s Biological and Medicinal Chemistry Sector (BMCS) and the Drug Metabolism Discussion Group (DMDG)


April 29, 2021
Online Event

Known colloquially as the "Hatfield MedChem" meeting, this is a highly successful, long-standing, one-day annual meeting. The meeting aims to be informal and interactive, and offers excellent scientific development and networking opportunities for all those working in medicinal chemistry and drug discovery.

For more information please contact: maggi@maggichurchouseevents.co.uk

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)


EFMC Sponsored Event

May 4-5, 2021
Online Event

Members from across the DMPK research community are encouraged to join colleagues from across academic, industrial, and third-sector institutions and contribute to the ongoing discussion, evolution and application of DMPK in various scenarios.

The event programme will incorporate sessions themed around the following key topics:
- DMPK and Drug Discovery
- DMPK and Drug Safety
- Analytical and Computational Advances in DMPK

In addition, the programme also includes a keynote talk, ‘flash’ presentations from early career researchers, and opportunities for open debate and discussion.

For more information please contact: 

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)

May 19-21, 2021
Bragança, Portugal

This award is attributed by the Divisions of Organic Chemistry and Therapeutic Chemistry of the Portuguese Chemical Society (SPQ), and aims to promote knowledge and reasoning in these areas developed by young researchers.

From November 19 to Febraury 8, 2021: registration and submission of the retrosynthesis proposal

From March 1 to April 5:  submission of the synthesis proposal

Final presentation of applications at the National Meeting of Young Portuguese Chemists (PyCHEM) in May 2021.

For more information please contact: 

Organised by:
  • Division of Medicinal Chemistry of the Portuguese Chemical Society (Portugal)

June 2021
Serbia

The aim of the Meeting is the presentation and discussion of recent results of chemists in Serbia and neighbouring countries in all the fields related to chemistry, chemical engineering and metallurgy. The scientific program, conducted through plenary type sessions, will reflect the structure of preceding meetings.

special committee will review all the Proceedings and corresponding posters presented during the meeting. On the basis of manuscript and poster originality, the quality of the experimental results and presentation clarity, the Committee will announce the three best posters that will be awarded the IUPAC Poster Prize. 

For more information please contact: office@shd.org.rs

Organised by:
  • Serbian Chemical Society, Division of Medicinal Chemistry (Serbia)

June 2-4, 2021
Madrid, Spain

The 3rd RSC / SCI / SEQT Symposium on Medicinal Chemistry for Global Health is organized by the Royal Society of Chemistry’s Biological and Medicinal Chemistry Sector (RSC BMCS), the Society of Chemical Industry’s Fine Chemicals Group (SCI FCG) and the Spanish Society of Medicinal Chemistry (SEQT). The meeting will be held at GlaxoSmithKline facilities in Tres Cantos (Madrid, Spain). This meeting will focus on medicinal chemistry approaches to developing new medicines for diseases affecting global health. Keynote talks from international experts from industry and academia, alongside perspectives detailing case histories in drug discovery, will highlight the latest developments in the field whilst also showcasing the opportunity for creativity and innovation.

For more information please contact: 


Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)
  • Sociedad Española de Química Terapéutica (Spain)

June 9-11, 2021
Kuopio, Finland

The Chemical Sciences in Biological Challenges combines life and health sciences with bio- and natural sciences. In the conference chemical sciences meet the challenges of biological environments from the perspective of drug development, environmental sciences as well as circular economy. The Key note lecturers are the top scientists on the fields of various disciplines, e.g. NMR spectroscopy, pharmacology, medicinal chemistry, organic synthesis, peptide research etc.

For more information please contact: 

Organised by:
  • Finnish Pharmaceutical Society (Finland)

June 16-18, 2021
Denmark

June 18, 2021
Barcelona, Spain

The Spanish Society of Medicinal Chemistry (SEQT) has the pleasure to invite you to join the 7th Symposium of Medicinal Chemistry Young Researchers. The meeting will be held in Barcelona Science Park on June 18th, 2021. At this event, young scientists (Post-doc, Pre-doc, Master’s degree, and Bachelor’s degree students) will have the opportunity to present their work in the form of oral, flash and poster presentations. Besides, registration is also open to both junior and senior researchers. As in former editions, attendees will have the opportunity to show and discuss their results in Medicinal Chemistry, and related areas, such as pharmacology, organic synthesis, molecular biology, computational chemistry, chemical biology, natural products, biotechnology, biochemistry and crystallography.

For more inforation contact: 

Organised by:
  • Sociedad Española de Química Terapéutica (Spain)

June 23, 2021
Tel-Aviv, Israel
Organised by:
  • The Medicinal Chemistry Section of the Israel Chemical Society (Israel)

June 27-30, 2021
Vilnius, Lithuania

BOS 2021, Vilnius constitutes the 11th biennial international conference on organic synthesis. The BOS conference main aims have remained unchanged during this long eighteen years history:

  • to convey the excitement of synthetic organic chemistry as practiced in industry and universities worldwide;
  • to promote interactions between chemists of different countries in order to create links, collaborations, common research projects in both, academic and industrial settings.

Programme

  • Invited lectures by a distinguished roster of Baltic and international speakers.
  • A balanced program of academic and industrial speakers presenting fundamental and practical aspects of organic synthesis.
  • Poster sessions held in a congenial atmosphere to stimulate discussion.
  • A full social programme with a reception, final banquet and city tours.
For more information please contact: 

June 27-July 1, 2021
Urbino, Italy

ESMEC 2021 is special, celebrating the 40th edition!

The mission of the ESMEC is to provide participants, PhD students and junior researchers from both academia and industry, with the most recent advances in the field of medicinal and organic chemistry, pharmacology, molecular biology and analytical/ structural chemistry. This idea is aimed to reflect the current scenario of medicinal chemistry being a truly transdisciplinary approach, where the advances in knowledge are driven by the medicinal chemist’s ability to translate into new molecular concepts and into novel molecular entities the amount of information created by molecular medicine, pharmacology, molecular biology, systems biology.

This year the scientific programme includes the following topics:

  • Proteolysis Targeting Chimera (Protac): From Medicinal Chemistry to Clinical Trials
  • Sustainable Chemistry Approaches To Lead Discovery and Chemical Processes
  • Medicinal Chemistry’s Response To the Burden of Antibiotic Resistance
  • Market Watch: New Drug Approval in 2019 and Synthetic Strategies

ESMEC Alumni Award

The ESMEC Alumni Award will be given to an outstanding European researcher in the field of Medicinal Chemistry who has participated in the school either as an oral or poster presenter.
 
The prize consists of a diploma, a medal and an invitation to give a presentation at ESMEC 2021.

For more information visit: www.esmec.eu

Organised by:
  • Division of Medicinal Chemistry of the Italian Chemical Society (Divisione di Chimica Farmaceutica - Società Chimica Italiana, DCF-SCI) (Italy)

June 27-30, 2021
New York City, United States

The American Chemical Society, Division of Medicinal Chemistry, is glad to invite you to New York City from Sunday, June 27 to Wednesday, June 30, 2021, for the 37th edition of the National Medicinal Chemistry Symposium.

As per its tradition, this dynamic four day symposium aims to bring together medicinal chemists from across the country working in the pharmaceutical industry, academia, government and private research institutions.

Attendees will be updated on the emerging techniques and applications within the field, and are encouraged to submit abstracts to share their ideas and results. Several poster prizes will be awarded during the meeting.

The Program of the 37th NMCS will include the following Sessions:

  • Integrating Novel Chemical Modalities in Hit-to-lead: a New Paradigm for Early Drug Discovery
    Chair: Maria-Jesus Blanco (SAGE Therapeutics)

  • New Directions in Targeting DNA Damage Repair (DDR)
    Chairs: Erin DiMauro (Merck & Co. Inc.) and Srinivasa Karra (Alkermes, Inc.)

  • Hot Targets from NYC Academic and Biotech Scene
    Chairs: Robert DeVita (Icahn School of Medicine at Mt Sinai) and Amjad Ali (Merck & Co. Inc.)

  • Targeting Autophagy for Cancer, Neurodegeneration, or Autoimmune Disease
    Chairs: Erin DiMauro (Merck & Co. Inc.) and Hongjun Zhang (Merck & Co. Inc.)

  • “If At First You Don’t Succeed, Try, Try, Try Again”: How Clinical Failures Propelled Next Generation Candidates
    Chair: Matthew Volgraf (Genentech Inc.)

  • Lessons from Drug Hunters across Academia, NPOs and the Pharmaceutical Industry
    Chair: Phil Kym (AbbVie)

In addition, the Program will also feature an Award Session.

For more information please contact:

June 29-30, 2021
Online Event

An ongoing series of conferences intended to provide expert advice and guidance to new practitioners in the field of drug discovery.

Deadline for abstract submission is June 4, 2021

For more information please contact: maggi@maggichurchouseevents.co.uk

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)


EFMC Sponsored Event

July 7-9, 2021
Virtual Meeting

The decision has been made to switch RICT 2021 into a fully virtual event. The programme will be reorganised to meet the needs of this Virtual Conference, but the dates will remain the same.

*****************************************************

The French Medicinal Chemistry Society (Société de Chimie Thérapeutique - SCT) is pleased to invite you to virtually attend the 56th edition of the International Conference on Medicinal Chemistry.

The congress will be devoted to “Interfacing Chemical Biology and Drug Discovery” and the main topics will be:

  • Chemistry in Living Systems & Chemical Biology for Targets Identification
  • Recent Advances in Targeted Protein-Protein Interactions Including Protein Degradation and Targeted Protein-DNA/RNA Interactions
  • Recent Trends in Drug Development for Neurodegenerative Diseases
  • Innovations in Cancer Therapeutics
  • Tackling New Challenges in Delivery Systems and Drug Formulation
  • Case Studies: Moving New Chemical Entities to the Market

As for previous editions of RICT, the scientific committee will ensure the high quality and diversity of the scientific programme together with the accessibility of the meeting to PhD/post-doc and local Master students. For the latter, an advantageous registration fee is proposed. Moreover, a special career session will be organised with industrial and academic participants.

poster session will provide the opportunity for all participants to present their current results. “Best poster” prizes will be attributed at the end of the meeting.

For more information contact:

Organised by:
  • Société de Chimie Thérapeutique (SCT) (France)

July 19-23, 2021
Porto, Portugal

For more information please contact: 

Organised by:
  • Division of Medicinal Chemistry of the Portuguese Chemical Society (Portugal)

August 22-26, 2021
Atlanta, Georgia

August 29 - September 1, 2021
Organised by:
  • Division of Medicinal Chemistry of the German Chemical Society (GDCh) (Germany)


EFMC Symposium

August 29 - September 2, 2021
Virtual Meeting

The International Organising Committee has decided that the XXVI EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2021) will be run as a fully Virtual Event, from August 29 to September 2, 2021. We are convinced that this is the right decision to allow many scientists to safely take part in this important scientific gathering.

Participants will be able to join the event via a digital platform, with content accessible during and after the symposium:

  • Online Sessions – Live broadcast of the full scientific programme, with Q&A for interaction with the speakers.
  • Replay – all sessions will be available on replay to all registered participants.
  • Virtual Poster Hall – for all participants to present and discuss their latest scientific results.
  • Virtual Exhibition – to give industry partners the opportunity to showcase products and novelties.

EFMC-ISMC 2021 will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, diseases of the brain, heart, and respiratory system, fibrotic diseases and cancer. EFMC-ISMC 2021 will also feature most recent advances in new technologiesuch as, artificial intelligence in drug discovery and chemical synthesis, the role carbohydrates in disease pathology and carbohydratge-based drug discovery, the exploitation of RNA as drug target, small molecule-induced stem cell differentiation, or the impact of cryo-EM on drug discovery and design. In a series of dedicated sessions, the interface between chemical biology and drug discovery will be highlighted, including topics such the use of chemical probes for target discovery, molecular imaging, and photochemical approaches. In response to frequent requests by attendees of previous conferences, two sessions will be dedicated to advances in synthetic methodology for drug discovery. Finally, particular emphasis will again be put on first time disclosures and recent highlights in medicinal chemistry.

More information available on www.efmc-ismc.org

Organised by:
  • Division for Medicinal Chemistry & Chemical Biology (DMCCB) (Switzerland)
  • European Federation for Medicinal Chemistry and Chemical Biology (EFMC)


EFMC Symposium

September 9-10, 2021
Virtual Meeting

The 8th edition of the EFMC Young Medicinal Chemists' Symposium will be held virtually on September 9-10, 2021 and will be organised by the European Federation for Medicinal Chemistry and Chemical Biology (EFMC) and the EFMC Young Scientists Network (YSN).

We had big hopes to be able to hold it in Basel, Switzerland at the initial date, but the lasting COVID-19 pandemic will continue to impact our lives and the way we can meet and travel through 2021.

Because we care about your health, the committee took the decision to run a fully virtual event – and prepare it upfront to offer you a digital platform to access the content during and after the symposium. The same reason lays behind our decision to postpone the event by one week and hold it on September 9-10, 2021 – as many of you will surely attend the XXVI EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2021) and we want to give your mind and eyes the time to rest.

The Programme of the 8th EFMC Young Medicinal Chemists’ Symposium will include:

  • keynote lectures given by inspiring leaders in the field, with ample time for interaction with the speakers.
  • oral communications by invited prize winners from national young medicinal chemist meetings in Europe
  • flash poster presentations selected from submitted abstracts
  • a virtual poster session open to any young researcher submitting an abstract
  • a virtual exhibition
  • prizes
    • EFMC-YMCS Presentation Prize
    • EFMC-YMCS Poster Prizes
    • EFMC-YMCS Public's Choice Prize

The scientific programme will also be completed by a series of soft-skills trainings and networking breaks, provided to you by the EFMC Young Scientists Network.

The EFMC Young Medicinal Chemists’ Symposium is an initiative of the European Federation for Medicinal Chemistry (EFMC) and is open to any scientist interested by the topics related to medicinal chemistry and chemical biology.

Organised by:
  • Division for Medicinal Chemistry & Chemical Biology (DMCCB) (Switzerland)
  • European Federation for Medicinal Chemistry and Chemical Biology (EFMC)

September 10, 2021
Lausanne, Switzerland

The Swiss Chemical Society Fall Meeting is the largest annual scientific event in Switzerland. It offers a unique opportunity for graduate students, post-doctoral researchers and scientists of all levels, from both, academia and industry, to share the results of their research projects. It also stimulates the exchange of ideas between all generations of chemists, often creating the seeds for new projects and collaborations.

The Scientific Program will offer invited and contributed lectures as well as poster presentations in the following fields:
- Analytical Sciences
- Catalysis Science & Engineering
- Chemistry and the Environment
- Computational Chemistry
- Inorganic & Coordination Chemistry
- Medicinal Chemistry & Chemical Biology
- Organic Chemistry
- Physical Chemistry
- Polymers, Colloids & Interfaces
- Chemical Education

For more information contact: Prof. Sandrine Gerber at

Organised by:
  • Division for Medicinal Chemistry & Chemical Biology (DMCCB) (Switzerland)

September 12-15, 2021
Cambridge, United Kingdom

Europe’s premier biennial Medicinal Chemistry event, focussing on first disclosures and new strategies in Medicinal Chemistry.

Deadline for abstract submission is April 30, 2021

For more information please contact: maggi@maggichurchouseevents.co.uk


Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)


EFMC Sponsored Event

September 19-23, 2021
Barcelona, Spain

EuroQSAR Symposia are taking place since 1973 and constitute major scientific events in the field of computational drug design, with further applications in agricultural and environmental sciences.

The program will include the following sessions:

  • QSAR without Borders
  • Artificial Intelligence in Drug Design
  • Molecular Dynamics and Kinetics
  • Chemical Space Annotation and Expansion
  • Modelling Drug Safety
  • Challenges in GPCR Drug Design
  • Modelling Drug Transport Mechanisms
  • Predicting Off-Target Pharmacology
  • Network Medicine
  • New Modes of Target Interaction
  • New Trends in Quantum Mechanics
  • Future Challenges Ahead

The 23rd EuroQSAR Symposium, entitled “Integrative Data-Intensive Approaches to Drug Design”, is organised on behalf of QCMS and is chaired by Jordi Mestres (IMIM Hospital del Mar Medical Research Institute).

Deadline for early bird registration and abstract submission for Oral Communications: June 11, 2020

Deadline for abstract submission for Poster Presentation: Auguste 4, 2020

For more information contact: 

September 21, 2021
Ljubljana, Slovenia

For more information please contact: Ziga.Jakopin@ffa.uni-lj.si

Organised by:
  • Section for Medicinal Chemistry of the Slovenian Pharmaceutical Society (Slovenia)

September 26-29, 2021
Brazil

October 3-10 2021
Leysin, Switzerland

This five-day Medicinal Chemistry School that is organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society will focus on most modern aspects associated with small molecule drug discovery, highlighting the methodologies and technologies supporting hit generation, lead finding and lead optimization campaigns.

In the beautiful and scenic village of Leysin, close to Lake Geneva, more than 100 young scientists are expected to meet with app. 35 international renowned expert speakers and instructors.

As in previous years, the teaching content will be targeted at young scientists working in the area of medicinal chemistry, but also from flanking disciplines such as biochemistrypharmacypharmacology, or biophysics from the pharmaceutical and biotech industry. Given the broad spectrum and the timeliness of scientific topics discussed, the course also provides a valuable opportunity for advanced medicinal chemists to get acquainted with most recent developments in e.g. the medicinal chemistry of novel target families, novel compound classes, and most modern optimization paradigms. In addition, a number of PhD students and postdocs will be able to attend to receive a broad overview on scientific disciplines involved in modern drug discovery.

The upcoming event will thematically be structured along key topics of strategic relevance for medicinal chemistry that will be presented by opinion leaders in the field. The teaching content will further be intensified by hands-on tutorials in which the theoretical learning’s can immediately be applied to real life problems of pre-clinical drug discovery.

Organised by:
  • Division for Medicinal Chemistry & Chemical Biology (DMCCB) (Switzerland)


EFMC Short Course

October 2021
Oegstgeest (near Leiden), The Netherlands

Due to the exceptional circumstances faced with the coronavirus pandemic (COVID-19), the 16th EFMC Short Course on Medicinal Chemistry has been postponed to Autumn 2021. More info about the date and registration will be provided soon. 

************************************************************

This intensive course is intended for scientists working in the field, and the presentations will be given by senior scientists from industry and academia. The number of participants is limited to 35, to allow in depth discussion. Should the number of applications exceed the maximum, preference will be given to applicants from EFMC adhering countries and employees of EFMC corporate members. Upon special request to the organisers, only based on financial conditions and supported by an argued recommendation of the head of the department of the applicant, up to 3 applicants from academia may be admitted at a reduced fee.

Course Outline

G-protein coupled receptors represent the largest class of drug targets. Although they serve as targets for about 30% of the known drugs, many of them is still orphan. In the last 15 years, however, we witnessed dramatic developments in the structural biology and pharmacology of GPCRs. High resolution X-ray and cryo-EM structures made the design of the GPCR ligands more rational. The widening knowledge on their signalling resulted in new concepts such as allosteric modulation, GPCR residence time and biased signalling currently tested in clinical trials. This course will provide an introduction for medicinal chemists to this important target class including concepts and methods applied in the structural biology, modelling, systems biology, pharmacology and medicinal chemistry of GPCRs.  The course will finish with a series of medicinal chemistry case studies, including the discovery of molecular probes, tool compounds, clinical candidates and marketed drugs.

Course Organisers

György Miklós KESERÜ (Research Centre for Natural Sciences, Hungarian Academy of Sciences, Hungary)
Rob LEURS (VU University Amsterdam, The Netherlands)

Local Organisers
Henk TIMMERMAN (VU University Amsterdam, The Netherlands)
Laura HEITMAN (University of Leiden, The Netherlands)

October 20-22, 2021
Albacete, Spain

The Spanish Society of Medicinal Chemistry (SEQT) has the pleasure to invite you to join the XIII SEQT Symposium, scheduled to be held on October 20-22, 2021 at Faculty of Pharmacy facilities in Albacete, Spain. This event will be an excellent opportunity to merge together highly experienced senior scientists from Spain and other European countries, imparting invited and plenary lectures, with students (post-graduated and postdoctoral) and junior researchers. As in previous editions, attendees will have the opportunity to access the latest advances and trends in drug discovery from both an academy and industry perspective.

For more inforation contact: 

Organised by:
  • Sociedad Española de Química Terapéutica (Spain)


EFMC Sponsored Event

November 19, 2021
Liege, Belgium

The Medicinal Chemistry Divisions of the two Belgian Chemical Societies, the Société Royale de Chimie (SRC) and the Koninklijke Vlaamse Chemische Vereniging (KVCV), are organising every year an international one-day symposium with the aim to update participants on selected areas of pharmaceutical research by specialists in their respective field.

MedChem 2020 will be held on Friday November 19, 2021, in Liège. The programme of the day will include 12 invited lectures and a poster session.

This year, the symposium will celebrate the 50th birthday of the Medicinal Chemistry division of the SRC and of the precursor association of today’s Bioorganic and Medicinal Chemistry division of the KVCV. On that special occasion, 12 speakers from 8 Belgian academic groups and 4 Belgian industries will provide an overview of cutting-edge research activities carried out in the country.  Through high quality talks and a variety of innovative themes, the symposium will highlight the current vibrancy of Belgian medicinal chemistry and its bright future. 

Check the list of confirmed speakers!

Organised by:
  • Société Royale de Chimie (SRC), Medicinal Chemistry Division (Belgium)
  • Medicinal and Bioorganic Chemistry Division of Royal Flemish Chemical Society (KVCV) (Belgium)

December 2021
Lille, France
Organised by:
  • Société de Chimie Thérapeutique (SCT) (France)

March 20-24, 2022
San Diego, California


EFMC Symposium

2022
Boston, United States

August 21-25, 2022
Chicago, Illinois


EFMC Symposium

September 4-8, 2022
Nice, France
Organised by:
  • Société de Chimie Thérapeutique (SCT) (France)
  • European Federation for Medicinal Chemistry and Chemical Biology (EFMC)

March 26-30, 2023
Indianapolis, Indiana

August 13-17, 2023
San Francisco, California


EFMC Symposium

September 3-7, 2023
Zagreb, Croatia

Symposium Chairs: 

  • Prof. Karl Gademann, Universirty of Zurich, Switzerland
  • Dr Ingo Hartung, Merck, Germany 
Organised by:
  • Croatian Chemical Society, Section of Medicinal/Pharmaceutical Chemistry (Croatia)
  • European Federation for Medicinal Chemistry and Chemical Biology (EFMC)

March 17-21, 2024
New Orleans, Louisianna

August 18-24, 2024
Denver, Colorado


EFMC Symposium

September 1-5, 2024
Rome, Italy
Organised by:
  • Division of Medicinal Chemistry of the Italian Chemical Society (Divisione di Chimica Farmaceutica - Società Chimica Italiana, DCF-SCI) (Italy)
  • European Federation for Medicinal Chemistry and Chemical Biology (EFMC)

March 23-27, 2025
San Diego, California

August 17-21, 2025
Washington, District of Columbia